{"id":4021,"date":"2021-11-24T09:33:50","date_gmt":"2021-11-24T09:33:50","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=4021"},"modified":"2021-11-26T09:34:20","modified_gmt":"2021-11-26T09:34:20","slug":"selection-dans-le-best-of-the-liver-meeting-2021","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/selection-dans-le-best-of-the-liver-meeting-2021\/","title":{"rendered":"S\u00e9lection dans le Best of The Liver Meeting 2021"},"content":{"rendered":"

Â鶹Æƽâ°æ a \u00e9t\u00e9 s\u00e9lectionn\u00e9e dans le “Best of The Liver Meeting 2021” pour sa pr\u00e9sentation orale d\u00e9crivant les effets cl\u00e9s de Vonafexor apr\u00e8s 12 semaines de traitements sur les fonctions du foie et du rein de patients NASH, donn\u00e9e par le PI de l’\u00e9tude LIVIFY Pr Stephen Harrison lors de la session Late Breaking 1, dimanche 14 novembre 2021. <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Â鶹Æƽâ°æ a \u00e9t\u00e9 s\u00e9lectionn\u00e9e dans le “Best of The Liver Meeting 2021” pour sa pr\u00e9sentation orale d\u00e9crivant les effets cl\u00e9s de Vonafexor apr\u00e8s 12 semaines de traitements sur les fonctions du foie et du rein de patients NASH, donn\u00e9e par le PI de l’\u00e9tude LIVIFY Pr Stephen Harrison lors de la session Late Breaking 1, dimanche 14 novembre 2021. <\/p>\n

\"\"<\/p>\n

Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-4021","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"Br\u00e8ves<\/a>","rttpg_excerpt":"Â鶹Æƽâ°æ a \u00e9t\u00e9 s\u00e9lectionn\u00e9e dans le “Best of The Liver Meeting 2021” pour sa pr\u00e9sentation orale d\u00e9crivant les effets cl\u00e9s de Vonafexor apr\u00e8s 12 semaines de traitements sur les fonctions du foie et du rein de patients NASH, donn\u00e9e par le PI de l’\u00e9tude LIVIFY Pr Stephen Harrison lors de la session Late Breaking…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4021"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4021\/revisions"}],"predecessor-version":[{"id":4022,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4021\/revisions\/4022"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}